In South Africa, health authorities have launched a trial campaign of the Johnson & Johnson COVID-19 vaccine as they battle a coronavirus variant that’s become dominant across southern Africa. The pivot to the Johnson & Johnson vaccine came after a small clinical trial showed the AstraZeneca vaccine failed to prevent most cases of mild and moderate disease in South Africa. South African officials have pledged to share unused doses of the AstraZeneca shot with other African nations.
South Africa Switches to Johnson & Johnson Vaccine in Battle Against Coronavirus Variant
HeadlineFeb 19, 2021